Related content

A phase I pharmacokinetics study of 9-nitrocamptothecin in patients with advanced solid tumors

By Yan Zhao   Zhu Zhongling   Li Kai   Chen Peng   Wang Liuchun   Huang Chun   Xue Jinhuai   Liu Meijun  

Cancer Chemotherapy and Pharmacology, Vol. 67, Iss. 4, 2011-04 ,pp. : 955-961

Springer Publishing Company

Access to resources Recommend Favorite

A phase II trial of gemcitabine plus capecitabine for patients with advanced pancreatic adenocarcinoma

By Park Byeong-Bae   Park Joon   Lee Hyo   Lee Jeeyun   Choi Dong   Choi Seong-Ho   Heo Jin   Lee Jong   Lee Kyu   Lim Do   Park Young   Lim Ho-Yeong   Kang Won   Park Keunchil  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 4, 2007-09 ,pp. : 489-494

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study - docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma

By Rougier P.   Adenis A.   Ducreux M.   de Forni M.   Bonneterre J.   Dembak M.   Clouet P.   Lebecq A.   Baille P.   Lefresne-Soulas F.   Blanc C.   Armand J.P.  

European Journal of Cancer, Vol. 36, Iss. 8, 2000-05 ,pp. : 1016-1025

Elsevier

Access to resources Recommend Favorite

Multicentre phase II and pharmacokinetic study of RFS2000 (9-nitro-camptothecin) administered orally 5 days a week in patients with glioblastoma multiforme

By Raymond E.   Campone M.   Stupp R.   Menten J.   Chollet P.   Lesimple T.   Fety-Deporte R.   Lacombe D.   Paoletti X.   Fumoleau P.   for the EORTC Early Clinical Studies Group ECSG B.T.S.G..a.N.D.D.P..  

European Journal of Cancer, Vol. 38, Iss. 10, 2002-07 ,pp. : 1348-1350

Elsevier

Access to resources Recommend Favorite

Phase II Study of Gemcitabine, UFT and Leucovorin in Patients with Advanced Pancreatic Cancer

By Kim Tae Won   Kang Hae Jin   Ahn Jin Hee   Lee Keehyun   Chang Heung Moon   Kang Yoon Koo   Lee Jung Shin  

Acta Oncologica, Vol. 41, Iss. 7-8, 2002-11 ,pp. : 689-694

Informa Healthcare

Access to resources Recommend Favorite